Accumulation Trend $HSGX

Nice increase in accumulation and a bullish trend. I'm long on this one and patience is a virtue waiting on a news update about the status with the FDA concerning filing a BLA after their review of the PH3 results. Remember, the PH3 trial only failed by Histogenics standards and not by the FDA's standard. With approval from the FDA Histogenics will be the top dogs in the market for knee repair. GLTA